Investor Presentation
40
Investor presentation First six months of 2022
The total branded diabetes market has a global value of DKK
-310 billion annually
DKK
Global diabetes market
billion
DKK
billion
The USA
+7%
400
150
143 139
2021
2020
Growth at CER
+10%
-10%
+24%
100
313
69
58
-9%
293
300
50
41 48
+14%
14 17
19 17
200
100
0
Total
-2%
112 117
Insulin
0
Total
Insulin
GLP-1
DPP-4i
SGLT-2i
Outside the USA
DKK
billion
+28%
+11%
170 154
150
97
+3%
-3%
78
+26%
-1%
100
55 58
71 70
+36%
+36%
49
40
40 41
50
29 21
30 23
0
GLP-1
DPP-4i
SGLT-2i
Total
Insulin
GLP-1
DPP-4i
SGLT-2i
Source: Company announcements as of Q4 2021
Note: The segment value is based on reported figures, whilst the market growth is under constant exchange rate (CER). For Novo Nordisk the diabetes growth includes Insulin and GLP-1, excluding 'other Diabetes care'.
Novo NordiskⓇView entire presentation